Historical shareholding details of iShares Biotechnology ETF holdings in Repligen Corp. (RGEN)

Monthly changes of iShares Biotechnology ETF shareholding in Repligen Corp. over the previous months

Month Name Total no. shares held Percent Holding
Feb 28, 2025 Ishares Biotechnology Etf 309,328 0.55%
Feb 26, 2025 Ishares Biotechnology Etf 321,856 0.57%
Jan 31, 2025 Ishares Biotechnology Etf 328,468 0.59%
Jan 29, 2025 Ishares Biotechnology Etf 329,164 0.59%
Dec 31, 2024 Ishares Biotechnology Etf 338,212 0.60%
Dec 30, 2024 Ishares Biotechnology Etf 340,047 0.61%
Nov 30, 2024 Ishares Biotechnology Etf 355,083 0.63%
Nov 27, 2024 Ishares Biotechnology Etf 359,289 0.64%
Oct 31, 2024 Ishares Biotechnology Etf 366,589 0.65%
Oct 30, 2024 Ishares Biotechnology Etf 369,312 0.66%
Oct 29, 2024 Ishares Biotechnology Etf 369,312 0.66%
Sep 30, 2024 Ishares Biotechnology Etf 380,658 0.68%
Sep 27, 2024 Ishares Biotechnology Etf 379,926 0.68%
Sep 25, 2024 Ishares Biotechnology Etf 382,854 0.68%
Aug 30, 2024 Ishares Biotechnology Etf 381,618 0.68%
Aug 29, 2024 Ishares Biotechnology Etf 382,151 0.68%
Aug 28, 2024 Ishares Biotechnology Etf 379,263 0.68%
Jul 31, 2024 Ishares Biotechnology Etf 383,980 0.69%
Jul 29, 2024 Ishares Biotechnology Etf 386,134 0.69%
Jun 28, 2024 Ishares Biotechnology Etf 385,416 0.69%
Jun 13, 2024 Ishares Biotechnology Etf 382,356 0.68%
May 29, 2024 Ishares Biotechnology Etf 373,483 0.67%
Apr 26, 2024 Ishares Biotechnology Etf 387,647 0.69%
Mar 27, 2024 Ishares Biotechnology Etf 390,783 0.70%
Feb 28, 2024 Ishares Biotechnology Etf 398,258 0.71%
Jan 29, 2024 Ishares Biotechnology Etf 390,421 0.70%
Dec 27, 2023 Ishares Biotechnology Etf 385,629 0.69%
Nov 29, 2023 Ishares Biotechnology Etf 356,685 0.64%
Oct 27, 2023 Ishares Biotechnology Etf 370,769 0.66%
Sep 27, 2023 Ishares Biotechnology Etf 377,323 0.68%
Aug 29, 2023 Ishares Biotechnology Etf 367,325 0.66%
Jul 28, 2023 Ishares Biotechnology Etf 369,890 0.66%
Jun 21, 2023 Ishares Biotechnology Etf 374,762 0.67%
May 30, 2023 Ishares Biotechnology Etf 376,909 0.68%

View all ownership details of Repligen Corp.